ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

House Committee Allocates NCI $1.347 Billion, $189 Million Over President’s Request For 1987

August 1, 1986

NCI Advisory Group, Other Cancer Meetings

October 26, 1984

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

Rumors Preceded Broder’s Move

December 22, 1994

Funding Opporunities: Program Announcments

January 15, 1999